source
- FDA proposes 50% fee cut for US early-stage trials, but industry says speed matters moreThe FDA announced a proposal to cut the application fee by half for drugs that run their early-stage trials in the United States. The reduction, about $2.3 million at current rates, is intended to…
- Takeda R&D chief Andy Plump to retire in June 2027 after 12-year tenureTakeda announced that its longstanding head of research and development, Andy Plump, will step down and retire in June 2027. Plump has been with the Japanese drugmaker for about 12 years, leading…